We are live on ! Find out more
Lazard Asset Management

Lazard Asset Management Portfolio holdings

AUM $60.8B
1-Year Est. Return 22.47%
This Fund
S&P 500
This Quarter Est. Return
+0.1%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$68.4B
AUM Growth
-$6.42B
Cap. Flow
-$9.95B
Cap. Flow %
-14.55%
Top 10 Hldgs %
25.74%
Holding
2,605
New
281
Increased
825
Reduced
894
Closed
234

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$433M
2
MRK icon
Merck
MRK
+$286M
3
J icon
Jacobs Solutions
J
+$265M
4
EFX icon
Equifax
EFX
+$253M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$240M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$710M
2
JNJ icon
Johnson & Johnson
JNJ
+$574M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$480M
4
MRVL icon
Marvell Technology
MRVL
+$377M
5
WFC icon
Wells Fargo
WFC
+$333M

Sector Composition

Rank Sector Weight
1 Technology 26.04%
2 Financials 14.64%
3 Healthcare 12%
4 Industrials 10.54%
5 Consumer Discretionary 9.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
P
2051
Everpure Inc
P
$27.8B
$1K ﹤0.01%
21
-18
-46% -$1K
REAX icon
2052
Real Brokerage
REAX
$377M
$1K ﹤0.01%
+416
New +$2.18K
RF icon
2053
Regions Financial
RF
$27.2B
$1K ﹤0.01%
67
+11
+20% +$272
RGEN icon
2054
Repligen
RGEN
$8.95B
$1K ﹤0.01%
8
-4
-33% -$574
ROL icon
2055
Rollins
ROL
$18.1B
$1K ﹤0.01%
29
– –
SAN icon
2056
Banco Santander
SAN
$209B
$1K ﹤0.01%
375
-3
-0.8% -$14
FIRY
2057
Firy Inc
FIRY
$154M
$1K ﹤0.01%
+290
New +$1.55K
STIM icon
2058
Neuronetics
STIM
$164M
$1K ﹤0.01%
+750
New +$780
STM icon
2059
STMicroelectronics
STM
$47.1B
$1K ﹤0.01%
50
– –
TAL icon
2060
TAL Education Group
TAL
$6.71B
$1K ﹤0.01%
116
– –
TECH icon
2061
Bio-Techne
TECH
$11.2B
$1K ﹤0.01%
16
– –
TROW icon
2062
T. Rowe Price
TROW
$24.5B
$1K ﹤0.01%
+15
New +$1.74K
UUUU icon
2063
Energy Fuels
UUUU
$3.11B
$1K ﹤0.01%
+302
New +$1.87K
VFC icon
2064
VF Corp
VFC
$5.98B
$1K ﹤0.01%
50
– –
WAT icon
2065
Waters Corp
WAT
$39.3B
$1K ﹤0.01%
3
-5
-63% -$1.83K
WFC.PRL icon
2066
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.67B
$1K ﹤0.01%
145
– –
WST icon
2067
West Pharmaceutical
WST
$24.7B
$1K ﹤0.01%
4
– –
XPEV icon
2068
XPeng
XPEV
$11.2B
$1K ﹤0.01%
162
– –
DAY
2069
DELISTED
Dayforce
DAY
$1K ﹤0.01%
20
– –
ABEO icon
2070
Abeona Therapeutics
ABEO
$388M
$0 ﹤0.01%
116
– –
ACET icon
2071
Adicet Bio
ACET
$85.6M
$0 ﹤0.01%
26
– –
ACHC icon
2072
Acadia Healthcare
ACHC
$3B
– –
-1,355
Closed -$85K
ACLX
2073
DELISTED
Arcellx
ACLX
$0 ﹤0.01%
9
– –
ACMR icon
2074
ACM Research
ACMR
$5.52B
– –
-846
Closed -$17K
ACNB icon
2075
ACNB Corp
ACNB
$663M
– –
-252
Closed -$11K
81 82
83
84 85

Similar funds

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Aviva
Aviva London, United Kingdom $59.6B AUM 28.44% 1-Year Est. Return
Mitsubishi UFJ Financial Group
Mitsubishi UFJ Financial Group Tokyo, Japan $62.1B AUM 41.06% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Lazard Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Lazard Asset Management held 2,605 positions worth $68.4B, down 8.6% from $74.8B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Lazard Asset Management withdrew a net $9.95B in Q4 2024, closing 234 positions and reducing 894 holdings. Its most notable exit was Atlantica Sustainable Infrastructure plc Ordinary Shares, an estimated $210M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Lazard Asset Management opened a new position in Vaxcyte worth $39.8M.

  • Lazard Asset Management's largest Q4 2024 buy was Vaxcyte: 486,764 shares worth $39.8M.
  • Lazard Asset Management added most to Eli Lilly in Q4 2024, an estimated $433M increase.
  • Lazard Asset Management's biggest Q4 2024 reduction was Microsoft, cutting an estimated $710M.
  • Lazard Asset Management fully exited Atlantica Sustainable Infrastructure plc Ordinary Shares in Q4 2024, selling an estimated $210M.
  • Lazard Asset Management's ten largest holdings make up 26% of its $68.4B portfolio in Q4 2024.
  • Lazard Asset Management opened 281 new positions and closed 234 in Q4 2024.
  • Lazard Asset Management's portfolio value fell 8.6% quarter-over-quarter to $68.4B.

Based on Lazard Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.